tiprankstipranks
Trending News
More News >
PTC Therapeutics (PTCT)
NASDAQ:PTCT

PTC Therapeutics (PTCT) Similar Stocks

Compare
405 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
PTC Therapeutics
$78.57
$6.31B
9.18
69.92%
8 Buy
5 Hold
1 Sell
Moderate Buy
TG Therapeutics
$30.98
$4.92B
11.15
-3.79%
3 Buy
0 Hold
1 Sell
Moderate Buy
Merus
$97.01
$7.36B
-18.18
131.80%
0 Buy
14 Hold
0 Sell
Hold
Crispr Therapeutics AG
$55.86
$5.32B
38.34%
12 Buy
7 Hold
0 Sell
Moderate Buy
Vaxcyte
$46.42
$6.08B
-9.43
-46.15%
7 Buy
0 Hold
0 Sell
Strong Buy
Arcellx Inc
$64.13
$3.74B
-14.96%
15 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PTCT
PTC Therapeutics
78.57
32.33
69.92%
TGTX
TG Therapeutics
30.98
-1.22
-3.79%
MRUS
Merus
97.01
55.16
131.80%
CRSP
Crispr Therapeutics AG
55.86
15.14
37.18%
PCVX
Vaxcyte
46.42
-40.11
-46.35%
ACLX
Arcellx Inc
63.96
-11.58
-15.33%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts